National Research Corp Stock Performance

NRC Stock  USD 10.66  0.03  0.28%   
The company secures a Beta (Market Risk) of 0.72, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Research is expected to be smaller as well. At this point, National Research Corp has a negative expected return of -0.77%. Please make sure to verify National Research's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if National Research Corp performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days National Research Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more

Actual Historical Performance (%)

One Day Return
5.53
Five Day Return
2.1
Year To Date Return
(38.17)
Ten Year Return
(27.18)
All Time Return
(57.26)
Forward Dividend Yield
0.0449
Payout Ratio
0.4599
Forward Dividend Rate
0.48
Dividend Date
2025-04-11
Ex Dividend Date
2025-03-28
1
NRC Health Partners with UC Health to Enhance Healthcare Consumer Experience
02/11/2025
2
Keybank National Association OH Purchases 33,518 Shares of Lam Research Co. - MarketBeat
03/07/2025
3
NANO Nuclear Energy Confirmed as Reactor Designer of KRONOS MMR by U.S. Nuclear Regulatory Commission
03/11/2025
4
Oklo Engaging with U.S. Nuclear Regulatory Commission in Pre-Application Readiness Assessment
03/24/2025
5
National Research Will Pay A Dividend Of 0.12
03/28/2025
6
Dow wants to power its Texas manufacturing complex with new nuclear reactors instead of natural gas
03/31/2025
7
Acquisition by Andrew Monnich of 100000 shares of National Research subject to Rule 16b-3
04/07/2025
8
A New Era of Trust NRC Healths 2025 Experience Perspective Report Reveals Insights to Elevate the Healthcare Experience
04/10/2025
9
NANO Nuclear and University of Illinois Urbana-Champaign Receive Nuclear Regulatory Commission Fuel Qualification Methodology Approval for KRONOS MMR Energy Sys...
04/22/2025
Begin Period Cash Flow6.7 M

National Research Relative Risk vs. Return Landscape

If you would invest  1,790  in National Research Corp on January 23, 2025 and sell it today you would lose (721.00) from holding National Research Corp or give up 40.28% of portfolio value over 90 days. National Research Corp is generating negative expected returns assuming volatility of 3.4523% on return distribution over 90 days investment horizon. In other words, 30% of stocks are less volatile than National, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon National Research is expected to under-perform the market. In addition to that, the company is 2.06 times more volatile than its market benchmark. It trades about -0.22 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.12 per unit of volatility.

National Research Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for National Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National Research Corp, and traders can use it to determine the average amount a National Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2224

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNRC

Estimated Market Risk

 3.45
  actual daily
30
70% of assets are more volatile

Expected Return

 -0.77
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average National Research is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Research by adding National Research to a well-diversified portfolio.

National Research Fundamentals Growth

National Stock prices reflect investors' perceptions of the future prospects and financial health of National Research, and National Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.

About National Research Performance

By analyzing National Research's fundamental ratios, stakeholders can gain valuable insights into National Research's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.39  0.24 
Return On Capital Employed 0.36  0.28 
Return On Assets 0.19  0.20 
Return On Equity 0.79  0.50 

Things to note about National Research Corp performance evaluation

Checking the ongoing alerts about National Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National Research Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
National Research generated a negative expected return over the last 90 days
National Research has high historical volatility and very poor performance
National Research has a poor financial position based on the latest SEC disclosures
About 45.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: NANO Nuclear and University of Illinois Urbana-Champaign Receive Nuclear Regulatory Commission Fuel Qualification Methodology Approval for KRONOS MMR Energy System
Evaluating National Research's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate National Research's stock performance include:
  • Analyzing National Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Research's stock is overvalued or undervalued compared to its peers.
  • Examining National Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating National Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Research's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of National Research's stock. These opinions can provide insight into National Research's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating National Research's stock performance is not an exact science, and many factors can impact National Research's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for National Stock analysis

When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios